Derma Sciences, a tissue regeneration company based in Princeton, has promoted an executive to president of advanced wound care, it said Thursday.Russell Olsen is CEO and president of BioD LLC, a ...

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has purchased the MEDIHONEY® brand ...

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in ...

Derma Science Inc., a Princeton-based tissue regeneration company, announced Monday that its board of directors has appointed Stephen T. Wills to serve as interim executive chairman and principal ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that it has been awarded a research ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J. Quilty, the Company’s ...

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June ...

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced positive results from its Phase 2 clinical trial with DSC127 in ...

Barry Wolfenson, 609-514-4744Executive Vice President of Marketing and Business DevelopmentorKim Sutton Golodetz, 212-838-3777orBruce Voss, 310-691-7100@LHA_IR_PRorMackenzie Mills, 212-838-3777orJ.

Investors certainly have to be happy with Derma Sciences Inc DSCI and its short term performance. After all, the stock has jumped by 7.4% in the past 4 weeks, and it is also above its 20 Day Simple ...

One stock that might be an intriguing choice for investors right now is Derma Sciences Inc. DSCI. This is because this security in the Medical/Dental-Supplies space is seeing solid earnings estimate ...

Add Yahoo as a preferred source to see more of our stories on Google. Here's the current margin snapshot for Derma Sciences over the trailing 12 months: Gross margin is 35.4%, while operating margin ...